Possible mechanisms for PIVKA-II production in HCC include qualitative orquantitative abnormality of prothrombin precursors, altered activity of gamma-glutamylcarboxylase, and abnormality in the vitamin K cycle or a lack of vitamin K.9 Similar mechanisms for PIVKA-II production could occurin HCA. This evidence concerns the gene F2 and hepatocellular carcinoma.